• CDK9 inhibitor (A3294): Lab Workflow Guide

  2026-08-24

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation and HIV-1 propagation inhibition without treating the compound as a general cytotoxic agent. It is suitable for focused biochemical and cellular pathway experiments, but not for pan-CDK inhibition, broad cell-cycle regulation studies, or protocols that require long-term storage of prepared solutions.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Assay Guide

  2026-08-24

  Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, can separate mRNA uptake from functional translation in viability, proliferation, cytotoxicity, and nanoparticle studies. This scenario-based guide covers assay design, handling, interpretation, and practical vendor-selection criteria.

• p-Cresyl sulfate Workflows for CKD Research

  2026-08-23

  Build reproducible p-Cresyl sulfate models for endothelial dysfunction, valvular calcification, and uremic toxin clearance research. This guide connects concentration-controlled cell assays with albumin-aware interpretation, fresh-solution handling, and mechanistic validation through the klotho/SIRT1 axis.

• Griseofulvin: From Spindle Poison to Assay Logic

  2026-08-22

  Griseofulvin is a microtubule associated inhibitor with value beyond routine antifungal testing. This article develops a mechanism-first strategy that connects fungal mitosis phenotypes with modern aneugenicity assay logic while defining the limits of that comparison.

• Leptin (116-130), amide, mouse: Translational Strategy

  2026-08-21

  A thought-leadership perspective on how Leptin (116-130), amide, mouse can connect energy homeostasis regulation with immunometabolic and cardiovascular research while keeping mechanistic claims, assay design, and translational limits clearly defined.

• Palmitic acid: Protocol and QC Guide

  2026-08-20

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid for lipid metabolism, insulin signaling, inflammation, and protein palmitoylation workflows. It is unsuitable for aqueous stock preparation and long-term solution storage, so solvent selection, matched vehicle controls, and prompt use are central to reproducible assays.

• SGI-1027 and Everolimus in Renal Cancer

  2026-08-20

  A 2024 Advanced Science study identifies SGI-1027 as an inducer of vacuolation and methuosis in renal cancer cells and shows that it cooperates with everolimus to suppress malignant phenotypes. The combination links lysosomal membrane permeability to apoptosis and GSDME-dependent pyroptosis, offering a mechanistic strategy for investigating everolimus resistance.

• Carboplatin in 3D Ovarian Cancer Models

  2026-08-19

  Carboplatin is a platinum-based DNA synthesis inhibitor whose activity can change substantially between 2D monolayers and 3D tumor models. This evidence-focused guide connects proteomic model selection with practical assay design for preclinical oncology research.

• Anlotinib Hydrochloride in Angiogenesis Assays

  2026-08-19

  Build mechanism-aware angiogenesis workflows around Anlotinib hydrochloride, from endothelial migration and tube formation to receptor and ERK pathway validation. This guide connects quantitative assay design with a translational cancer case while emphasizing controls, optimization, and research-use limitations.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-08-18

  Sulfo-NHS-LC-Biotin is a water-soluble reagent for covalent biotin labeling of accessible primary amines on proteins, peptides, and intact-cell surfaces. It is suited to irreversible extracellular labeling and streptavidin-based capture, but not to intracellular or reversible biotinylation workflows.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-18

  The reference study shows that puerarin enhances the osteogenic differentiation of rat dental follicle cells and links this effect to nitric oxide, cyclic GMP, soluble guanylate cyclase, and PKG-1 signaling. Its inhibitor-based design provides a useful framework for testing nitric oxide pathway modulation during periodontal regeneration research, while also highlighting limitations in cell-model and pathway specificity.

• FAISL, FAK Proteolysis, and TNBC Metastasis

  2026-08-17

  The 2024 Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis. Its findings connect lncRNA-dependent control of FAK protein turnover with triple-negative breast cancer adhesion, survival, progression, and metastasis, while providing a rationale for FAISL-targeted RNA delivery.

• Apigenin Workflows for Oncology and Neuroprotection

  2026-08-17

  Apigenin supports parallel oncology and neuroprotection workflows by combining HDAC-linked apoptosis studies with ROS, DNA-damage, mitochondrial, and inflammation readouts. This practical guide covers dosing, assay design, cross-model interpretation, and troubleshooting for more reproducible preclinical experiments.

• Spermine: Designing Causal Ion Channel Assays

  2026-08-16

  Spermine is an endogenous polyamine whose voltage-dependent control of IRK1 channels makes it valuable for disciplined ion channel regulation studies. This evidence-calibrated guide connects channel assays with emerging herpesvirus nuclear egress research while separating established mechanisms from testable hypotheses.

• Rottlerin: A PKC Probe for Entry Biology

  2026-08-15

  Rottlerin is a PKC inhibitor with applications extending from apoptosis and cell proliferation to mechanistic studies of pathogen entry. This article develops an assay-centered framework connecting Rottlerin pharmacology with Spiroplasma eriocheiris uptake in Drosophila S2 cells while emphasizing controls, interpretation, and cross-domain limitations.

7942 records 1/530 page Next 12345 下5页 Last page